Survivorship Care Must Include Quality of Life for Patients

AONN+ Blog published on December 11, 2017 in Survivorship
Lillie D. Shockney, RN, BS, MAS, HON-ONN-CG
Editor-in-Chief, JONS; Co-Founder, AONN+; University Distinguished Service Professor of Breast Cancer, Professor of Surgery, Johns Hopkins University School of Medicine; Co-Developer, Work Stride-Managing Cancer at Work, Johns Hopkins Healthcare Solutions

For more than a century, cancer care had a singular goal―to have the patient survive the disease and its treatment. With that achieved, the treatment team smiled, considering the treatment a success. Times have changed, and thankfully, treatments have changed, too. Patients now have much higher expectations of what constitutes a success story. The goals have expanded beyond just surviving, and include preservation or restoration of the person’s quality of life, too.

 

 
Related Items
Acute Survivorship
Kimberlee Rowett, DNP (c), MSN, MBA, RN
Webinars published on July 3, 2024 in Survivorship
Stages of Survivorship: Extended Survivorship
Jason King, RN, BSN, OCN
Webinars published on July 3, 2024 in Survivorship
The objectives of this webinar session are:
  • Define the “extended” survivorship phase.
  • Review cancer survivor facts and figures.
  • Identify immediate effects of cancer treatment.
  • Identify strategies for addressing the unique needs of cancer survivors in this stage.
  • Discuss the navigator’s role in evaluating, assessing, and planning follow-up care.
Stages of Survivorship: Permanent/Long-Term Survivorship
Megan Solinger, MHS, MA, OPN-CG, Pam Plasket, RN, BSN, OCN, CHPN
Webinars published on July 3, 2024 in Survivorship
The objectives of this webinar session are:
  • Define the “permanent/long-term” survivorship phase
  • Review cancer survivor facts and figures
  • Identify the prevalent concerns/needs of survivors in this phase
  • Identify strategies to address survivor needs in this phase
  • Discuss navigator’s role in evaluating, assessing and planning follow-up care
  • Discuss special considerations for the AYA and transplant population in this phase